The generative ai in healthcare market size has grown exponentially in recent years. It will grow from $3.23 billion in 2025 to $4.44 billion in 2026 at a compound annual growth rate (CAGR) of 37.2%. The growth in the historic period can be attributed to digitization of healthcare data, advancement in machine learning algorithms, growth of electronic health records, investment in healthcare it, demand for efficiency.
The generative ai in healthcare market size is expected to see exponential growth in the next few years. It will grow to $13.11 billion in 2030 at a compound annual growth rate (CAGR) of 31.1%. The growth in the forecast period can be attributed to regulatory acceptance of ai tools, growth in clinical ai adoption, expansion of real-world data usage, increased hospital automation, ai-driven personalized care. Major trends in the forecast period include increasing use of AI-assisted clinical decision support, expansion of ai in medical imaging analysis, growing adoption of virtual nursing assistants, integration of ai in workflow automation, rising use of predictive healthcare analytics.
The growing demand for personalized medicine is expected to drive the growth of the generative AI in healthcare market in the coming years. Personalized medicine, also called precision medicine, is an innovative approach to treatment that considers individual variability in genes, environment, and lifestyle. The rising interest in personalized medicine is fueled by advancements in genomics, better understanding of disease mechanisms, and the need for more effective, targeted therapies. Generative AI in healthcare uses algorithms to analyze large amounts of patient data, including genetic profiles and medical histories, to develop personalized treatment options and predictions tailored to individual patients. For example, in February 2024, the Personalized Medicine Coalition, a UK-based organization promoting personalized medicine, reported that the FDA's Center for Drug Evaluation and Research (CDER) approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. These approvals included seven cancer-specific medications and three treatments for other diseases and conditions. Therefore, the increasing demand for personalized medicine is driving the generative AI in healthcare market.
Leading companies in the generative AI in healthcare market are forming strategic partnerships to develop innovative technologies and gain a competitive advantage. Such collaborations advance generative AI in healthcare by combining the strengths and resources of multiple organizations to create new solutions, improve clinical workflow efficiency, and address key healthcare challenges. For instance, in June 2023, Google, a US-based technology company, partnered with Mayo Clinic, a US-based nonprofit focused on clinical practice, to integrate generative AI into healthcare. This collaboration aims to leverage generative AI to streamline operations and enhance healthcare delivery by unlocking previously inaccessible information and enabling real-time, personalized interactions. The initial focus is on Enterprise Search in Gen App Builder to optimize clinical workflows and patient outcomes while ensuring HIPAA compliance.
In July 2024, GE HealthCare, a US-based provider of medical imaging, diagnostics, and healthcare IT solutions, partnered with Amazon Web Services (AWS) to accelerate the development of cloud-based imaging and AI-enabled clinical workflows. Through this partnership, GE HealthCare aims to utilize AWS’s generative AI infrastructure to improve diagnostic insights, optimize clinical workflows, and accelerate the adoption of AI-driven healthcare solutions. AWS, a US-based company, provides scalable cloud computing, AI/ML tools, and generative AI model hosting services.
Major companies operating in the generative ai in healthcare market are Alphabet Inc., Microsoft Corporation, Amazon Web Services Inc., Johnson & Johnson Services Inc., Siemens AG, Intel Corporation, IBM Watson Health Corporation, Oracle Corporation, Nvidia Corporation, Epic Systems Corporation, Persistent Systems Private Limited, Tempus Labs Inc., Eleks Inc., Verge Genomics Inc., PathAI Inc., BenevolentAI Ltd, Abridge AI Inc., Absci Corporation, Atomwise Inc., Syntegra, Insilico Medicine, DiagnaMed Holdings Corp.
North America was the largest region in the generative AI In healthcare market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generative ai in healthcare market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the generative ai in healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the generative ai in healthcare market by increasing costs of imported computing hardware, data infrastructure components, and specialized software systems. Hospitals and diagnostic centers are most affected due to reliance on imported technologies. These tariffs raise implementation costs by increasing spending on servers, data storage, and system integration, slowing adoption of AI-enabled clinical solutions. However, they encourage local AI infrastructure development, supporting domestic data centers, regionally developed software platforms, and localized healthcare AI ecosystems.
The generative ai in healthcare market research report is one of a series of new reports that provides generative ai in healthcare market statistics, including generative ai in healthcare industry global market size, regional shares, competitors with a generative ai in healthcare market share, detailed generative ai in healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the generative ai in healthcare industry. This generative ai in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Generative AI in healthcare refers to the application of advanced artificial intelligence models tailored to address the specific needs and challenges of medical practice. These models can create detailed simulations using real-world data, enabling researchers and medical professionals to test hypotheses in a safe environment. They are used to generate new insights and data that can enhance patient outcomes, accelerate medical research, and improve the delivery of healthcare services.
The main components of generative AI in healthcare are solutions and services. Services are non-physical, intangible elements of the economy, in contrast to tangible goods that can be touched or handled. They encompass functions such as AI-assisted robotic surgery, virtual nursing assistants, support in clinical decision-making or diagnosis, workflow and administrative tasks, and image analysis. These services are applied in areas such as clinical care and healthcare systems and are used by various end-users, including hospitals and clinics, clinical research organizations, healthcare providers, diagnostic centers, and others.
The generative AI in healthcare market includes revenues earned by entities by providing services such as drug discovery process, medical imaging, medical research, personalized treatment plans, medical simulations, and detecting billing fraud. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The generative ai in healthcare market size is expected to see exponential growth in the next few years. It will grow to $13.11 billion in 2030 at a compound annual growth rate (CAGR) of 31.1%. The growth in the forecast period can be attributed to regulatory acceptance of ai tools, growth in clinical ai adoption, expansion of real-world data usage, increased hospital automation, ai-driven personalized care. Major trends in the forecast period include increasing use of AI-assisted clinical decision support, expansion of ai in medical imaging analysis, growing adoption of virtual nursing assistants, integration of ai in workflow automation, rising use of predictive healthcare analytics.
The growing demand for personalized medicine is expected to drive the growth of the generative AI in healthcare market in the coming years. Personalized medicine, also called precision medicine, is an innovative approach to treatment that considers individual variability in genes, environment, and lifestyle. The rising interest in personalized medicine is fueled by advancements in genomics, better understanding of disease mechanisms, and the need for more effective, targeted therapies. Generative AI in healthcare uses algorithms to analyze large amounts of patient data, including genetic profiles and medical histories, to develop personalized treatment options and predictions tailored to individual patients. For example, in February 2024, the Personalized Medicine Coalition, a UK-based organization promoting personalized medicine, reported that the FDA's Center for Drug Evaluation and Research (CDER) approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. These approvals included seven cancer-specific medications and three treatments for other diseases and conditions. Therefore, the increasing demand for personalized medicine is driving the generative AI in healthcare market.
Leading companies in the generative AI in healthcare market are forming strategic partnerships to develop innovative technologies and gain a competitive advantage. Such collaborations advance generative AI in healthcare by combining the strengths and resources of multiple organizations to create new solutions, improve clinical workflow efficiency, and address key healthcare challenges. For instance, in June 2023, Google, a US-based technology company, partnered with Mayo Clinic, a US-based nonprofit focused on clinical practice, to integrate generative AI into healthcare. This collaboration aims to leverage generative AI to streamline operations and enhance healthcare delivery by unlocking previously inaccessible information and enabling real-time, personalized interactions. The initial focus is on Enterprise Search in Gen App Builder to optimize clinical workflows and patient outcomes while ensuring HIPAA compliance.
In July 2024, GE HealthCare, a US-based provider of medical imaging, diagnostics, and healthcare IT solutions, partnered with Amazon Web Services (AWS) to accelerate the development of cloud-based imaging and AI-enabled clinical workflows. Through this partnership, GE HealthCare aims to utilize AWS’s generative AI infrastructure to improve diagnostic insights, optimize clinical workflows, and accelerate the adoption of AI-driven healthcare solutions. AWS, a US-based company, provides scalable cloud computing, AI/ML tools, and generative AI model hosting services.
Major companies operating in the generative ai in healthcare market are Alphabet Inc., Microsoft Corporation, Amazon Web Services Inc., Johnson & Johnson Services Inc., Siemens AG, Intel Corporation, IBM Watson Health Corporation, Oracle Corporation, Nvidia Corporation, Epic Systems Corporation, Persistent Systems Private Limited, Tempus Labs Inc., Eleks Inc., Verge Genomics Inc., PathAI Inc., BenevolentAI Ltd, Abridge AI Inc., Absci Corporation, Atomwise Inc., Syntegra, Insilico Medicine, DiagnaMed Holdings Corp.
North America was the largest region in the generative AI In healthcare market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generative ai in healthcare market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the generative ai in healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the generative ai in healthcare market by increasing costs of imported computing hardware, data infrastructure components, and specialized software systems. Hospitals and diagnostic centers are most affected due to reliance on imported technologies. These tariffs raise implementation costs by increasing spending on servers, data storage, and system integration, slowing adoption of AI-enabled clinical solutions. However, they encourage local AI infrastructure development, supporting domestic data centers, regionally developed software platforms, and localized healthcare AI ecosystems.
The generative ai in healthcare market research report is one of a series of new reports that provides generative ai in healthcare market statistics, including generative ai in healthcare industry global market size, regional shares, competitors with a generative ai in healthcare market share, detailed generative ai in healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the generative ai in healthcare industry. This generative ai in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Generative AI in healthcare refers to the application of advanced artificial intelligence models tailored to address the specific needs and challenges of medical practice. These models can create detailed simulations using real-world data, enabling researchers and medical professionals to test hypotheses in a safe environment. They are used to generate new insights and data that can enhance patient outcomes, accelerate medical research, and improve the delivery of healthcare services.
The main components of generative AI in healthcare are solutions and services. Services are non-physical, intangible elements of the economy, in contrast to tangible goods that can be touched or handled. They encompass functions such as AI-assisted robotic surgery, virtual nursing assistants, support in clinical decision-making or diagnosis, workflow and administrative tasks, and image analysis. These services are applied in areas such as clinical care and healthcare systems and are used by various end-users, including hospitals and clinics, clinical research organizations, healthcare providers, diagnostic centers, and others.
The generative AI in healthcare market includes revenues earned by entities by providing services such as drug discovery process, medical imaging, medical research, personalized treatment plans, medical simulations, and detecting billing fraud. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Generative AI in Healthcare Market Characteristics
3. Generative AI in Healthcare Market Supply Chain Analysis
4. Global Generative AI in Healthcare Market Trends and Strategies
5. Generative AI in Healthcare Market Analysis of End Use Industries
7. Global Generative AI in Healthcare Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Generative AI in Healthcare Total Addressable Market (TAM) Analysis for the Market
9. Generative AI in Healthcare Market Segmentation
10. Generative AI in Healthcare Market Regional and Country Analysis
11. Asia-Pacific Generative AI in Healthcare Market
12. China Generative AI in Healthcare Market
13. India Generative AI in Healthcare Market
14. Japan Generative AI in Healthcare Market
15. Australia Generative AI in Healthcare Market
16. Indonesia Generative AI in Healthcare Market
17. South Korea Generative AI in Healthcare Market
18. Taiwan Generative AI in Healthcare Market
19. South East Asia Generative AI in Healthcare Market
20. Western Europe Generative AI in Healthcare Market
21. UK Generative AI in Healthcare Market
22. Germany Generative AI in Healthcare Market
23. France Generative AI in Healthcare Market
24. Italy Generative AI in Healthcare Market
25. Spain Generative AI in Healthcare Market
26. Eastern Europe Generative AI in Healthcare Market
27. Russia Generative AI in Healthcare Market
28. North America Generative AI in Healthcare Market
29. USA Generative AI in Healthcare Market
30. Canada Generative AI in Healthcare Market
31. South America Generative AI in Healthcare Market
32. Brazil Generative AI in Healthcare Market
33. Middle East Generative AI in Healthcare Market
34. Africa Generative AI in Healthcare Market
36. Generative AI in Healthcare Market Competitive Landscape and Company Profiles
37. Generative AI in Healthcare Market Other Major and Innovative Companies
40. Generative AI in Healthcare Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Generative AI In Healthcare Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses generative ai in healthcare market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for generative ai in healthcare? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The generative ai in healthcare market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Component: Solutions; Services2) By Function: AI-Assisted Robotic Surgery; Virtual Nursing Assistants; Aid Clinical Judgment Or Diagnosis; Workflow And Administrative Tasks; Image Analysis
3) By Application: Clinical; System
4) By End User: Hospitals And Clinics; Clinical Research; Healthcare Organizations; Diagnostic Centers; Other End Users
Subsegments:
1) By Solutions: Diagnostic Imaging Analysis; Drug Discovery And Development Tools; Personalized Treatment Planning; AI-Powered Clinical Decision Support2) By Services: Consulting and Advisory Services; Implementation And Integration Services; Support And Maintenance Services; Training And Education Services
Companies Mentioned: Alphabet Inc.; Microsoft Corporation; Amazon Web Services Inc.; Johnson & Johnson Services Inc.; Siemens AG; Intel Corporation; IBM Watson Health Corporation; Oracle Corporation; Nvidia Corporation; Epic Systems Corporation; Persistent Systems Private Limited; Tempus Labs Inc.; Eleks Inc.; Verge Genomics Inc.; PathAI Inc.; BenevolentAI Ltd; Abridge AI Inc.; Absci Corporation; Atomwise Inc.; Syntegra; Insilico Medicine; DiagnaMed Holdings Corp.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Generative AI in Healthcare market report include:- Alphabet Inc.
- Microsoft Corporation
- Amazon Web Services Inc.
- Johnson & Johnson Services Inc.
- Siemens AG
- Intel Corporation
- IBM Watson Health Corporation
- Oracle Corporation
- Nvidia Corporation
- Epic Systems Corporation
- Persistent Systems Private Limited
- Tempus Labs Inc.
- Eleks Inc.
- Verge Genomics Inc.
- PathAI Inc.
- BenevolentAI Ltd
- Abridge AI Inc.
- Absci Corporation
- Atomwise Inc.
- Syntegra
- Insilico Medicine
- DiagnaMed Holdings Corp.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.44 Billion |
| Forecasted Market Value ( USD | $ 13.11 Billion |
| Compound Annual Growth Rate | 31.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
